Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Astellas Pharma Europe Ltd.

Clinical trials sponsored by Astellas Pharma Europe Ltd., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1
Sort by
  • Could a Once-Daily pill replace Twice-Daily dosing for young transplant patients?

    Disease control Completed

    This study tested whether children who had received an organ transplant (kidney, liver, heart, lung, or intestine) could safely switch from taking tacrolimus twice a day (Prograf) to a once-daily version (Advagraf). The goal was to see if the once-daily pill provided similar drug…

    Phase: PHASE2 • Sponsor: Astellas Pharma Europe Ltd. • Aim: Disease control

    Last updated Jun 27, 2026 08:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space